Medtronic PLC at JPMorgan Healthcare Conference Transcript
All right. Good morning, everybody, and thank you for joining us today. Before I begin, I would like to remind you that today's discussion will include forward-looking statements that are subject to risks and uncertainties, and so we encourage you to please reference our SEC disclosures.
Well, I'll start with saying, look, it's an exciting time for Medtronic. For the last several years, we've been working diligently towards this moment through engineering rigor, manufacturing expertise and regulatory know-how. And now we're in the fortuitous position to accelerate our revenue growth and our earnings growth. Today, we're going to talk about four key areas, accelerating on both what we call our generational growth drivers like PFA, Symplicity, Altaviva, Hugo and through our continuous pipeline of new technologies in areas like thrombectomy, carotid, spinal navigation and robotics, MMAe or in our case, Onyx, and many more.
And we're focused and hyper-focused on expanding margins, which will help us
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
